Output and Energy Shift After Magnetron Replacement
A 6 MV photon beam on a Clinac iX is used for approximately 45 patients daily. Following magnetron replacement and re-tuning by the service engineer, the medical physics team performs monthly QA. The reference chamber (0.6 cm³ Farmer, calibrated at a UK secondary standards laboratory, NK = 1.002, traceable) is set up at 10 cm depth, 100 cm SSD, 10 × 10 cm². The electrometer reading, corrected for temperature and pressure, is 3.8% higher than the baseline established at commissioning. The photon quality index (TPR20,10) has changed from 0.668 to 0.662. Flatness and symmetry are within 2%, and the light–radiation field coincidence is 1 mm. The linac is scheduled to treat 12 patients this afternoon, including two palliative spinal cord compression cases and a 33-fraction head and neck plan. The service engineer says the beam is 'within manufacturer specifications' and suggests treating. The duty physicist must decide.
1. Before any patient is treated, what measurements and checks would you perform to confirm or refute a genuine change in beam output and energy? Explain the reasoning behind each check.
Read the worked answer
Reasoning
A 3.8% output rise immediately after magnetron replacement must be treated as a possible genuine beam change until excluded. The first step is to validate the measurement chain, because a chamber or electrometer problem can mimic an output change.
- Reference conditions: confirm 10 cm depth, 100 cm SSD, 10 × 10 cm², correct temperature and pressure, chamber warm-up, pre-irradiation, and polarity/ion recombination corrections if used. A wrong depth or field size changes the reading by several percent.
- Dosimetry system: check the chamber calibration certificate is current, the correct calibration factor is applied, the electrometer range and leakage are acceptable, and the signal is stable over repeated readings. Repeat the measurement three times and with a second independent chamber.
- Beam quality: repeat TPR20,10 or measure percentage depth dose and J20/J10. A chamber problem usually changes output without changing energy; a genuine tuning change can alter both. Here TPR20,10 fell by 0.006, which is small but consistent with a lower-energy beam.
- Machine parameters: review the service report, magnetron tuning, gun servo, pulse-forming network, steering, monitor chamber calibration, and any changed beam energy setting. Check output constancy at other field sizes and SSD/SAD geometries.
- Independent verification: compare against daily constancy, annual reference dosimetry, and if available a second ion chamber or independent calculation. Do not rely on the service engineer's statement that the beam is 'within manufacturer specifications'; clinical tolerances are tighter.
The key judgement is that a chamber/electrometer fault is unlikely to explain a simultaneous small energy change, so a real beam change must be assumed until proven otherwise.
2. Apply typical QA tolerances and decide whether the linac can treat this afternoon. Address the palliative and radical patients specifically.
Read the worked answer
Reasoning
Typical photon output constancy tolerance is ±2% (tighter, ±1%, for SRS/SBRT), and energy constancy is often ±2% or about 0.01 in TPR20,10. A 3.8% output increase exceeds the output tolerance. The energy change of 0.006 is within a 2% energy tolerance, but it does not explain away the output error and may indicate that the beam was re-tuned to a different operating point. Flatness and symmetry being acceptable does not validate output.
Decision: the linac should not treat clinically until output is re-measured, the cause is understood, and the beam is recalibrated and independently verified. Treating a 3.8% high beam would systematically overdose every patient, including the head and neck plan where normal-tissue constraints are close.
- Palliative spinal cord compression: do not simply cancel. Transfer to a second linac if available, or treat after physics clearance on this unit. A short delay for safe dosimetry is preferable to a wrong dose, but the clinical urgency must be communicated to the on-call oncologist so that dexamethasone and analgesia are optimized and transfer is arranged.
- Head and neck radical plan: reschedule after recalibration. Do not treat with a 'temporary MU correction' unless the energy and output are fully characterized and the plan is recalculated or corrected under physics supervision.
- Patients already treated since the service: identify all fractions delivered after the magnetron replacement, estimate the dose error, and inform the oncologist for retrospective review.
Document the hold, the measurements, the decision, and the communication. The unit returns to service only after repeat QA within tolerance and a secondcheck of output and energy.
3. What governance, communication and root-cause actions should follow once the unit is safely managed?
Read the worked answer
Reasoning
The event is a potential systematic dosing error and must be handled as a quality incident, not just a physics inconvenience.
- Immediate governance: inform the duty manager, radiation protection supervisor, head of physics, and relevant oncologists. Record the QA failure, action taken, patients affected, and timings.
- Root-cause analysis: determine whether the magnetron installation or tuning changed the beam energy/output, whether the monitor chamber calibration was altered, and whether the service acceptance test was adequate. Review the service engineer's report and the machine log files.
- Patient review: for any patient treated after the service, calculate the delivered dose error using the measured output factor and energy change. If the error is clinically significant, arrange oncologist review, open disclosure, and documentation in accordance with local incident policy.
- Communication: tell treating radiographers why the unit is held, when it is expected back, and what to tell patients. Avoid unofficial workarounds.
- Learning: update the service-to-clinical handover checklist so that physics reference dosimetry is repeated and signed off before the first patient after major component replacement. Consider adding an independent daily output check after major service.
The safe culture is to stop, verify, and escalate rather than to accept an engineer's assurance.